Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|April 17, 2026
Integrative Transcriptomic and Machine Learning Analysis of ecDNA-Associated Features for Studying Chemotherapy Resistance in TNBCMd Iftehimul, Dipongkor SahaMethods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic VirotherapyDipongkor Saha, Samuel D RabkinOncolytic Virotherapy|March 4, 2021
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma TreatmentHong-My Nguyen, Dipongkor SahaStem Cell Reviews and Reports|October 20, 2023
Tumor Microenvironment: A Niche for Cancer Stem Cell ImmunotherapyMia C Borlongan, Dipongkor Saha, Hongbin WangCurrent Opinion in Virology|August 7, 2016
Oncolytic herpes simplex virus interactions with the host immune systemDipongkor Saha, Hiroaki Wakimoto, Samuel D RabkinVirus Genes|November 26, 2011
Instability in vitro of a PCV2 infectious clone containing an insertion between ORF1 and ORF2Dipongkor Saha, Jan V Doorsselaere, Hans J NauwynckCells|February 14, 2020
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer ImmunotherapyHong-My Nguyen, Kirsten Guz-Montgomery, Dipongkor SahaImmunotherapy|July 17, 2018
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastomaDipongkor Saha, Robert L Martuza, Samuel D RabkinComputational and Structural Biotechnology Journal|January 19, 2026
Temporal molecular remodeling of T cells informs their possible adaptation in 4T1 tumorsMd Iftehimul, Robert H Newman, Scott H Harrison, et al.Drugs of the Future|February 9, 2016
EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMADipongkor Saha, Seemin S Ahmed, Samuel D RabkinPageof 6